Matches in Wikidata for { <http://www.wikidata.org/entity/Q89683769> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q89683769 description "article scientifique publié en 2020" @default.
- Q89683769 description "artykuł naukowy opublikowany 14 marca 2020" @default.
- Q89683769 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q89683769 description "scientific article published on 14 March 2020" @default.
- Q89683769 description "wetenschappelijk artikel" @default.
- Q89683769 description "наукова стаття, опублікована 14 березня 2020" @default.
- Q89683769 name "Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations" @default.
- Q89683769 name "Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations" @default.
- Q89683769 type Item @default.
- Q89683769 label "Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations" @default.
- Q89683769 label "Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations" @default.
- Q89683769 prefLabel "Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations" @default.
- Q89683769 prefLabel "Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations" @default.
- Q89683769 P1433 Q89683769-0630C9C7-E1A4-4E0E-92F1-9EACAB7E9842 @default.
- Q89683769 P1476 Q89683769-D2F45C50-7320-47A6-B7EA-57C5D01FCC85 @default.
- Q89683769 P2093 Q89683769-1B3B21B4-32EF-449B-8410-7E53A74088D7 @default.
- Q89683769 P2093 Q89683769-5D64550A-2095-473A-8228-335411CD066B @default.
- Q89683769 P2093 Q89683769-5EA972B3-FBEE-47D4-B9E7-E9AAD703FFBF @default.
- Q89683769 P2093 Q89683769-6CC997A7-8F1F-4674-BCAE-C73E4C1C1F74 @default.
- Q89683769 P2093 Q89683769-81B6B87C-A24A-4BD0-BE3C-844B9F56A7A2 @default.
- Q89683769 P2093 Q89683769-A493FDE2-E1CA-4185-96BE-564EBDCA2EAF @default.
- Q89683769 P2093 Q89683769-AFFE772C-5621-4D24-BB5C-363523475855 @default.
- Q89683769 P2093 Q89683769-EE4337C4-ED89-4CE9-B4CC-A892BB3DF415 @default.
- Q89683769 P2093 Q89683769-FC785FC7-1497-4E6E-995E-330DE1631D96 @default.
- Q89683769 P275 Q89683769-0970F487-E856-4BEE-80D4-7273E376DD12 @default.
- Q89683769 P304 Q89683769-E9D172D8-6653-4C06-8B18-CF91CD497F47 @default.
- Q89683769 P31 Q89683769-6F297D4A-1295-49D7-8AFA-76F85D54195B @default.
- Q89683769 P356 Q89683769-E256C63F-BFA1-4D10-9C42-82F72F4BD59D @default.
- Q89683769 P577 Q89683769-8396D598-B8F3-493A-A626-3FBE37740D0E @default.
- Q89683769 P6216 Q89683769-CA8890AD-B69F-4054-AF05-F11E80272356 @default.
- Q89683769 P698 Q89683769-659509CC-75A2-4B27-9043-198754F67BBE @default.
- Q89683769 P356 03007995.2020.1729708 @default.
- Q89683769 P698 32050807 @default.
- Q89683769 P1433 Q5195063 @default.
- Q89683769 P1476 "Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations" @default.
- Q89683769 P2093 "Charl Els" @default.
- Q89683769 P2093 "Cristina Russ" @default.
- Q89683769 P2093 "Cynthia Arons" @default.
- Q89683769 P2093 "Hans Rollema" @default.
- Q89683769 P2093 "Ivan Berlin" @default.
- Q89683769 P2093 "Karl Fagerström" @default.
- Q89683769 P2093 "Peter Hajek" @default.
- Q89683769 P2093 "Serena Tonstad" @default.
- Q89683769 P2093 "Thomas McRae" @default.
- Q89683769 P275 Q24082749 @default.
- Q89683769 P304 "1-18" @default.
- Q89683769 P31 Q13442814 @default.
- Q89683769 P356 "10.1080/03007995.2020.1729708" @default.
- Q89683769 P577 "2020-03-14T00:00:00Z" @default.
- Q89683769 P6216 Q50423863 @default.
- Q89683769 P698 "32050807" @default.